Day One Biopharma Expands to ADCs with $55M Drug Acquisition
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
- Latest
- Trending
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
Discover how PTOUNX Exchange leads the cryptocurrency future with AI-driven features, enhanced security, and strict legal compliance.
High Tide Inc. reports 5% revenue growth & 111% same-store sales boost amid cannabis sector challenges, thanks to its unique ...
Dow Inc. leads global LDPE production with 2.6MM tons capacity; Univation dominates PE tech, supplying over one-third of global HDPE ...
E3technology enhances Empore™ membranes for better proteome sample prep, crucial for low-cell proteomics, say experts at UD and CDS Analytical.
BTC cloud mining is a viable alternative for increasing passive income by validating transactions on the Bitcoin blockchain. Learn how ...
The RBI's approval allows fintech firms in India to expand and compete more effectively. Paytm Payments Bank was ordered to ...
A new info-stealing malware called 'Cheat Lab' is spreading by posing as a game cheat, tricking users into infecting their ...
A software bug allowed gamblers to redeem two receipts and be paid the combined amount at a casino, resulting in ...
Paramount declines to comment on the report, as Redstone serves as NAI president. Ellison's plans for the rest of the ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.